Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development
SHANGHAI, June 28, 2023 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals Co., Ltd. (hereinafter referred to as Sanyou) and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963) (hereinafter referred to as Huadong Medicine), signed a license agreement for a collaboratively developed therapeutic biological product. This license is a continuation of the strategic partnership agreement...
Race executes global license agreement with City of Hope to access FTO IP
Race executes worldwide license agreement with City of Hope, one of the largest cancer research and treatment organisations in the United States. Under the agreement, Race will exclusively secure rights to a City of Hope patent application and associated know-how identifying that bisantrene may be the most potent inhibitor of the FTO pathway. Agreement grants Race freedom to explore...
Lunit Backs the Potential of Tertiary Lymphoid Structures Analysis as an Emerging Biomarker for Lung Cancer Treatment – to be presented at WCLC 2023
- A collaborative study demonstrates that AI analysis of Tertiary Lymphoid Structures (TLS) in tumors can predict treatment response in non-small cell lung cancer patients SEOUL, South Korea, Aug. 21, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of a groundbreaking study at the 2023 World Conference...
Baird Medical’s Single-Use Sterile Biopsy Needle Receives Approval from Jiangsu Medical Products Administration in China
GUANGZHOU, China, Sept. 5, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China, today announced that its subsidiary, Nanjing Changcheng Medical Equipment Co., Ltd., has received approval of its Single-Use Sterile Biopsy Needle ("SSBN") from Jiangsu Medical Products Administration, the drug regulatory body for...
Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)
Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience's anti-HER3 ADC to be developed for patients with HER3-expressing tumors Hummingbird Bioscience to receive upfront and milestone payments up to $430 million, plus royalties, from Endeavor BioMedicines Investigational New Drug (IND) application planned in first half of 2024 SAN DIEGO, HOUSTON and SINGAPORE,...
Foresee Pharmaceuticals to Present at the American Heart Association Annual Meeting Focusing on its ALDH2 activator FP-045 in Pulmonary Hypertension Associated with Interstitial Lung Disease
TAIPEI, Oct. 30, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today that the company will be presenting at the American Heart Association (AHA) 2023 Annual Meeting taking place in Philadelphia, PA, from November 11-13, 2023. The presentation will focus on Foresee's first-in-class oral ALDH2 activator, FP-045, and the clinical design of Phase 2 pulmonary hypertension associated...
Infinitus celebrates the 10th anniversary of its Si Li Ji Ren Education Dream Support Programme
The project aims to enhance innovation empowerment and provide scholarship program standards GUANGZHOU, China, Nov. 22, 2023 /PRNewswire/ -- On November 18, 2023, Infinitus and Si Li Ji Ren Foundation teamed up with China Philanthropy Times to host an event at Infinitus Plaza in Guangzhou, China celebrating the 10th anniversary of the Si Li Ji Ren Education Dream...
Fovia Ai to Showcase Optimized AI Visualization at IAIP Exhibit, RSNA 2023
Fovia Ai Provides Efficient AI Results in One Unified Viewer CHICAGO, Nov. 26, 2023 /PRNewswire/ -- Fovia Ai, Inc., a subsidiary of Fovia, Inc., a world leader in advanced visualization for over two decades and a preeminent provider of zero-footprint, cloud-based imaging SDKs, today announced that it will be showcasing AI interaction and visualization of AI results from...
Scantox acquires QPS Austria’s Neuropharmacology Division
EJBY, Denmark, Nov. 30, 2023 /PRNewswire/ -- Today Scantox, together with its majority owner Impilo, has agreed to acquire the neuropharmacology division of QPS Austria GmbH ("QPS Neuro" or "the Company") ultimately owned by QPS Holdings LLC. QPS Neuro is a leading drug discovery Contract Research Organization (CRO) that specializes in neurodegenerative, rare diseases and mental disorders. The Company is...
“No Perchlorate, Yes Non-electrolysis”…CJ FNT Introduces Natural Cysteine
FlavorNrich™ MASTER C L-Cysteine gives a healthier alternative to the market with growing demands for natural cysteine with no perchlorates SEOUL, South Korea, Dec. 4, 2023 /PRNewswire/ -- CJ Food & Nutrition Tech (CJ FNT) launched an online campaign showcasing its FlavorNrich™ MASTER C L-Cysteine to serve the growing demand for non-electrolytic cysteine....
